欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0874/002
药品名称Linagliptin-Metformin STADA 2.5mg/850mg film-coated tablet
活性成分
    • linagliptin 2.5 mg
    • Metformin hydrochloride 850.0 mg
剂型Film-coated tablet
上市许可持有人STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany
参考成员国 - 产品名称Hungary (HU)
互认成员国 - 产品名称
    • Slovakia (SK)
    • Austria (AT)
    • Lithuania (LT)
      Linagliptin/Metformin STADA 2,5 mg/850 mg plėvele dengtos tabletės
    • Malta (MT)
      Lipharmin 2.5mg/850mg film-coated tablets
    • Spain (ES)
    • Estonia (EE)
    • Greece (GR)
    • Czechia (CZ)
      Linagliptin/Metformin STADA
    • Latvia (LV)
许可日期2023/07/11
最近更新日期2024/11/27
药物ATC编码
    • A10BD11 metformin and linagliptin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase